Influence of the probiotic “Bioseven” on the intestinal biocenose of white rats

The use of probiotics in animal husbandry ensures the maintenance of homeostasis of the digestive tract and prevents the development of factor infections in young animals – colibacteriosis, dyspepsia, and others, promotes the growth of animals with high survival rates. The main advantages of probiotics over chemotherapeutic drugs and antibiotics are that they are harmless to animal organism and are ecologically clean. In connection with the great attention paid to probiotics as ecologically safe drugs, the study of biological properties and the selection of bacterial strains, the most promising in the probiotic sense, are currently being intensified. This is the direction of the selection of species-specific strains for the intestinal biocenosis of a specific animal species, which have high colonization and antagonistic properties. Therefore, the development of the scientific basis for the creation of new probiotic preparations gave an impetus to their improvement and continued research in this direction. The aim of the work was to study the effect of the probiotic “Bioseven” on the intestinal biocenosis of white rats depending on the dose. Objectives of the study: to establish the toxicity of the drug “Bioseven” on laboratory animals with a single dose (“acute toxicity”) according to microbiological indicators; to investigate the toxicity of “Bioseven” on laboratory animals with long-term administration (“subacute toxicity”) according to microbiological indicators. Research work was carried out during 2022 at the department of veterinary and sanitary examination, hygiene of animal husbandry products and pathanatomy named after J. S. Zagaevskii. The toxicological characterization of the probiotic drug “Bioseven” (study of subacute and acute toxicity) was carried out under the conditions of the State Research Control Institute of Veterinary Medicines and Feed Additives (Laboratory of Pharmacology and Toxicology), (Lviv), the manufacturer of the drug was PP “BTU-CENTER” Ladyzhyn, Vinnytsia region. On the 31st day of use of the drug “Bioseven” (a feed additive with probiotic action) in a therapeutic dose, microorganisms of the genus Lactobacillus were sown 0.3 lg CFU/g more from the large intestine of experimental rats, microorganisms of the genus Bifidobacterium were sown at 0.5 lg CFU/g more than in the control group. The number of Candida fungi decreased by 0.6 lg CFU/g, and the total number of Escherichia coli – 0.2 lg CFU/g. When using the “Bioseven” probiotic in a 5-fold therapeutic dose, 0.5 lg CFU/g more microorganisms of the Lactobacillus genus and 0.6 lg CFU/g more Bifidobacterium microorganisms were sown from the large intestine of experimental rats than in the control group. At the same time, the number of Candida fungi decreased by 0.7 lg CFU/g, and the total number of Escherichia coli to 0.4 lg CFU/g. Under the conditions of use of the drug “Bioseven” in a 10-fold therapeutic dose, microorganisms of the genus Lactobacillus were sown from the large intestine of experimental rats, 0.9 lg CFU/g more, microorganisms of the genus Bifidobacterium 1.2 lg CFU/g more than in the control the group At the same time, the number of Candida fungi decreased by 1.1 lg CFU/g, and the total number of Escherichia coli by 0.8 lg CFU/g. Prospects for further research consist in the study of the impact of the biotic drug “Bioseven” on indicators of metabolic processes and productive qualities of farm animals.